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endothelial layer is controversial in allografts. 2 The 
endothelium provides antithrombotic haracteristics 
which may turn into pro-thrombotic stimuli under 
several circumstances and, most importantly, it con- 
stitutes a great antigenic hallenge to the host. 
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Cytokine Profiles in Abdominal Aortic Aneurysms 
Sir, 
Louwrens and colleagues 1 present an interesting 
paper highlighting the important role of the plasmino- 
gen activator system in the pathogenesis ofabdominal 
aortic aneurysms (AAAs). The study indicates how 
the expression of the various components of this 
system might be cytokine dependent, in particular IL- 
1~. However, it seems that they are not fully up to date 
with the literature on cytokines and aneurysmal 
pathology. IL-I~ is not the only cytokine which has 
been found to be elevated in AAA wall in comparison 
with normal control aortas. A recent study by New- 
man et al. 2 demonstrated that both IL-I~ and TNF-a 
were significantly increased in AAA compared to 
cadaveric ontrols. In addition a more detailed study 
of the cytokinetic profile of AAA 3 showed that IL-2, 
IL-2 receptor, IFN-7 and IL-4 were all elevated in the 
aneurysmal wall. These mediators were absent in the 
control samples of human aorta. The role of the 
immune system is a fundamental part of the pathoge- 
nesis of AAAs and requires further detailed studies. 
I. Masood 
Leicester, U.K. 
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Quality of Life After Treatment of Intermittent 
Claudication 
S~ 
We were interested to read the recent paper by Currie 
et al. 1 demonstrating the impact of treatment of 
intermittent claudication on quality of life. Angio- 
plasty and surgery offer short-term improvement to 
quality of life but the effect of restenosis and graft 
occlusion may minimise this improvement or in the 
latter significantly reduce quality of life. In such a non- 
randomised trial it is also not surprising that patients 
in the operative group have lower baseline quality of 
life. Supervised exercise programmes undoubtedly 
increase xercise tolerance in compliant patients 2 but 
the authors have not reported the compliance rate of 
patients in their unsupervised exercise group. Patients 
who poorly comply with exercise would be unlikely to 
report significant improvement in quality of life. We 
have shown that a daily home exercise programme, 
supervised weekly by a physiotherapist for the first 
month achieves good compliance, increased walking 
distances and improved quality of life as assessed by 
the Nottingham Health Profile questionnaire. 3 
We share the authors concerns that exercise, 
although improving local symptoms may have 
adverse remote consequences with neutrophil activa- 
tion 4 and systemic vascular endothelial damage, s This 
may influence atherogenesis and therefore be impli- 
cated in the excess cardiovascular mortality in these 
patients. Surgery attenuates but does not normalise 
the increase in vascular permeability after treadmill 
exercise. 6 Angioplasty itself is effected by cracking of 
the atherosclerotic plaque, exposing the subintimal 
layer. Perhaps angioplasty also has an adverse effect 
on future cardiovascular mortality? We suggest hat 
we should have more information on the effect of 
therapeutic intervention on putative biochemical 
markers of vascular inflammation, rather than assess- 
ing outcome simply on the basis of quality of life. 
P. V. Tisi and C. P. Shearman 
Southampton, U.K. 
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The authors conclude that the low cost and 
improvement in QOL support the continued use of 
PTA in claudication. As only 26-40% of claudicants 
have lesions amenable to angioplasty, 3'4 the overall 
benefit on QOL in the patient group as a whole is 
decreased. In contrast, supervised exercise training 
programmes are applicable to all claudicants and are 
known to increase walking distance. 5 The beneficial 
effect of supervised exercise on QOL has not been 
reported. Some degree of exercise supervision is 
essential to provide encouragement and ensure com- 
pliance as unsupervised exercise has been reported to 
effect a minimal improvement in quality of life. 6 
P. V. Tisi and C. P. Shearman 
Southampton, U.K. 
Quality of Life Following Percutaneous 
Transluminal Angioplasty for Claudication 
Sir, 
The recent paper by Cook et al) showed that patients 
undergoing percutaneous transluminal angioplasty 
(PTA) have lower baseline quality of life (QOL) scores 
compared to a normal population and that revascular- 
isation improved QOL and walking distance score. We 
would like to make several points regarding this 
study. The authors have presumably used published 
figures for baseline EuroQOL scores in a normal 
population rather than comparing the 29 patients to an 
age and sex-matched control group, which would be 
more relevant Lower baseline QOL in claudicants 
compared to controls has recently been reported using 
the Nottingham Health Profile questionnaire. 2 
The EuroQOL questionnaire was completed on the 
ward prior to PTA and it is likely that the stress of 
admission to hospital would adversely affect the 
response to QOL parameters. It is possible that 
patients may also underestimate their subjective walk- 
ing distance score in order to ensure that the proce- 
dure is not cancelled due to spontaneous improve- 
ment in symptoms. Perhaps an objective treadmill 
assessment before and after PTA would more accu- 
rately reflect he correlation between improved walk- 
ing distance and QOL? The authors have failed to 
include the two patients with failed PTA in their 
analysis, although we accept hat surgery itself may 
improve QOL. A long-term assessment of the effect of 
PTA on QOL is needed as restenosis after the 6 week 
follow-up may significantly reduce the improvement 
compared to baseline levels, and may possibly lead to 
a deterioration. 
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Cranial Nerve Injuries and Carotid 
Endarterectomy 
Sir, 
Cranial nerve injuries following operations on the 
carotid bifurcation is an easily identifiable problem for 
patients but not for surgeons, at least not for all of 
them. In most reported series of carotid surgery, 
cranial nerve injuries (CNI) are infrequently men- 
tioned, and some authors have expressed the opinion 
that such injuries, should be reported only if they are 
permanent. 
In the November issue of the Journal, ~ D. Bergqvist 
and his co-workers reported the results of a very 
thorough prospective study, using the resources of the 
department of speech therapy on 689 carotid endarter- 
ectomies. As was expected, the incidence of cranial 
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